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ABSTRACT 
Elastosis in the breast is an unusual phenomenon and its morphogenesis has not yet been ful-
ly ascertained. The degree of elastosis in the breast associated with benign diseases, including 
fibroadenoma and fibrocystic disease as well as with breast carcinoma, was examined with spe-
cial reference to the correlation between the degree of epithelial proliferation and elastosis. Us-
ing the immunohistochemical method, the presence of elastase (EL) and a 1-antichymotrypsin 
(ACT), one of the protease inhibitors, in these epithelial cells was also investigated to elucidate 
the role of an imbalance in these enzymes in the morphogenesis of the elastosis. Consequently, 
it was shown that there is a tendency in fibroadenoma and fibrocystic disease, for epithelial 
proliferation to be related to the degree of elastosis, and that the lack of EL in proliferated 
epithelial cells might play a role in the occurrence of elastosis, although ACT has no significant 
correlation. On the contrary, in our study noninvasive carcinoma showed marked periductal elasto-
sis but no stromal elastosis, while invasive carcinoma showed various degrees of periductal and 
stromal elastosis. In invasive carcinoma, especially scirrhous carcinoma, the degree of ACT in 
cancer cells correlated well with stromal elastosis, although there was no correlation with EL. 
These findings suggest that an imbalance of the protease-antiprotease system, produced by 
epithelial cells of the breast, contribute to the morphogenesis of elastosis, although the physio-
logical event, aging, is only marginally related to elastosis. Further investigation of the cells 
producing elastin and regulatory factors may be necessary. 
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Elastosis in the breast, that is, the presence of 
clumps of elastic fibers which appear as eosinophilic 
hyaline acellular areas in section stained with 
hematoxylin-eosin, occurs at three anatomical sites, 
periductal, stromal and perivascular, and has been 
a focus of interest. In breast carcinoma, a number 
of studies have been made to ascertain the relation-
ship between the degree of elastosis and prognosis 
based on patients' outcome, but there is some 
controversy6>. Furthermore, it is now known that 
elastosis accompanies benign breast disease. With 
regard to benign breast disease, a hypothesis that 
the degree of elastosis increases progressively in 
fibrocystic disease with the severity of epitheliosis 
has been proposed30>. 
in the elastic fibers of the breast are associated 
with age, parity and reproductive status10>. Thus, 
elastosis in the breast remains a mysterious 
phenomenon since its morphogenesis has not been 
ascertained. Recently, a hypothesis was put forward 
regarding the morphogenesis of elastosis which pro-
posed that the presence of protease inhibitors might 
influence the metabolism of elastic fibers, facilitat-
ing elastic fiber proliferation by the inhibition of 
elastinolytic enzymes9>. 
However, it remains unclear whether elastosis is 
to be regarded as a nonspecific stromal reaction to 
the malignant or benign disease or constitutes a 
more active component of an associated disease 
process. Also, it has been suggested that changes 
The present study is directed towards showing 
the degree of elastosis in the breast associated with 
benign disease, including fibroadenoma and 
fibrocystic disease, as well as with breast carcino-
ma, with special reference to the correlation be-
tween the degree of epithelial proliferation and 
elastosis. It is speculated that the epithelial cells 
produce protease inhibitors and an attempt is made 
by the use of immunohistochemical method, to show 
the presence of elastase and a 1-antichymotrypsin, 
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one of the protease inhibitors, in these epithelial 
cells in order to examine the role of these enzymes 
in the morphogenesis of elastosis in the breast. 
MATERIALS AND METHODS 
1. Materials: One hundred and twenty-one mastec-
tomised female breasts with primary carcinoma 
were obtained from surgical files of Hiroshima 
University Hospital. The patients' ages ranged from 
31 to 82. The mastectomised breasts were fixed 
with formalin and 1 or 2 specimens from the main 
tumor in each case were used for the present study. 
Among the cases with carcinoma, the breasts of 69 
cases were cut by stepwise method with 5mm in-
tervals to examine non-neoplastic areas microscop-
ically, according to the method which we have 
previously reported19). Among 4412 specimens 
made from non-neoplastic areas, 32 lesions of radial 
scar measuring more than 3mm were detected. 
Radial scar was determined as a lesion with a cen-
tral fibroelastotic core surrounded by stellate 
proliferation of the duct system18•33•40). 
Fifty-six cases of fibroadenoma, most of which 
were obtained by excisional biopsy, and 23 biopsy 
cases diagnosed as fibrocystic disease only, were 
selected from the same surgical files. The age of 
patients with fibroadenoma or fibrocystic disease 
ranged from 16 to 72 and 26 to 73, respectively. 
In these cases of benign breast disease, represen-
tative sections were selected for microscopic exami-
nation. 
2. Staining. All sections were stained with hema-
toxylin-eosin (H&E), and in order to ascertain elas-
tic fibers, elastica-van-Gieson (EVG) staining was 
performed in all sections. 
3. Grading of elastosis: Elastosis in the breast was 
noted as three modes, that is: periductal, stromal 
and perivascular. The present study focused on the 
former two modes of elastosis because perivascu-
lar elastosis was thought to be influenced by fac-
tors other than epithelial cell proliferation. The 
elastosis was graded as follows: total lack of clumps 
of elastic fibers, negative (-); mild to moderate in-
crease of elastic fibers in the periductal region or 
the presence of newly formed-elastic fibers in the 
stroma, mild to moderate ( + ); prominent increase 
of elastic fibers in the periductal region and in the 
stroma, marked ( + + ). 
4. Immunohistochemistry. Among cases with breast 
carcinoma, 116 cases with periductal elastosis and 
102 cases with stromal elastosis were examined im-
munohistochemically, because in 5 cases with solid-
tubular carcinoma, the ductal component was ab-
sent, and in 19 cases with noninvasive ductal car-
cinoma, no stromal component was observed. All 
of the cases with fibroadenoma and fibrocystic dis-
ease were examined immunohistochemically. 
Serial sections of the microscopically examined 
section were prepared, and by means of the avidin-
biotin-peroxidase complex (ABC) method, localiza-
tion of elastase (EL) and a 1-antichymotrypsin 
(ACT) was examined. Polyclonal antibodies against 
EL and ACT were purchased from Ventrex 
Laboratories (Portland, USA) or Dako Co. Ltd. 
(Glostrup, Denmark), respectively. The antibodies 
against EL and ACT were used at a dilution of 1: 
200 and 1: 1500, respectively. As an internal con-
trol, the immunoreactivity of EL was observed at 
neutrophils infiltrated to the breast, and that of 
ACT at histiocytes. 
The immunohistochemical staining was evaluated 
as follows: total lack of staining in any of the 
epithelial cells, negative (-); less than 49% of the 
epithelial cells were positive or weakly positive, 
positive ( + ); more than 50% of the epithelial cells 
were positive and strongly positive, strongly posi-
tive ( + + ). 
RESULTS 
1. Incidence and degree of elastosis 
(1) Elastosis in fibroadenoma 
Cases with fibroadenoma were divided into three 
groups according to the patients' age, that is, be-
low 29, third decade and above 40 (Table 1). Elasto-
sis in fibroadenoma appeared to increase in 
incidence progressively with age, although no 
statistically significant difference was noted. Elasto-
sis in fibroadenoma was mostly of the stromal type. 
Epithelial proliferation was occasionally associat-
ed in the ducts or tubules of fibroadenoma (Fig. 
1-a). Marked stromal elastosis is seen in fibroade-
noma (Fig. 1-b). Cases were divided into three 
groups, according to the presence and degree of 
this change. The degree of elastosis in the special 
area showing the epithelial proliferation is shown 
in Table 2. Cases with more epithelial proliferation 
appeared to show a higher incidence of elastosis, 
although this tendency was not statistically sig-
nificant. 
(2) Elastosis in fibrocystic disease (epitheliosis) 
Elastosis in cases with fibrocystic disease was 
seen more frequently than in cases with fibroade-
noma (57% versus 34%). The type of elastosis was 
mostly periductal (Fig. 2-a). Marked periductal 
elastosis is seen in fibrocystic disease (Fig. 2-b ). 
Twenty-three cases with fibrocystic disease were 
Table 1. Relationship between Degree of Stromal Elasto-
sis in Fibroadenoma and Age of the Patients 
No. of cases (%) with stromal 
Total no. elastosis at degrees of: 
Age of cases + ++ 
~29 19 15 (79) 4 (21) 0 
30-39 15 10 (67) 4 (27) 1 (7) 
40~ 22 12 (55) 8 (36) 2 (9) 
Total 56 37 (66) 16 (29) 3 (5) 
(N.S.) 
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(a) (b) 
Fig. 1. Fibroadenoma with stromal elastosis and epithelial proliferation. (a: H&E stain, b: EVG stain, x 33) 
Table 2. Relationship between Degree of Stromal 
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divided into two groups according to the patients' 
age: below 39 and above 40. There was no corre-
lation between the patients' age and elastosis (Ta-
ble 3). Cases were divided into three groups 
according to the degree of ductal epithelial hyper-
plasia (epitheliosis). It appeared that the degree of 
elastosis was positively related to the degree of 
epitheliosis, although the number of cases was small 
(a) 
Table 3. Relationship between Degree of Periductal 
Elastosis in Fibrocystic Disease and Age of Patients 
No. of cases (%) with periductal 
Total no. elastosis at degrees of: 
Age of cases + ++ 
~39 10 4 (40) 4 (40) 2 (20) 
~40 13 6 (46) 6 (46) 1 (8) 
Total 23 10 (43) 10 (43) 3 (13) 
(N.S.) 
and there was no statistical difference (Table 4). 
(3) Elastosis in radial scar 
Radial scar was almost always associated with 
elastosis. The type was periductal (Fig. 3-a). 
Marked periductal elastosis is noted in radial scar 
(Fig. 3-b). The relation to patients' age was not sig-
nificant. Table 5 shows the correlation between the 
degree of elastosis and the degree of epithelial 
(b) 
Fig. 2. Fibrocystic disease with periductal elastosis and epithelial proliferation. (a: H&E stain, b: EVG 
stain, x33) 
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proliferation, which was not statistically significant. 
(4) Elastosis in breast carcinoma 
Breast carcinoma cases were divided into two 
groups according to the patients' age: below 49 and 
above 50. Cases above 50 years showed a higher 
incidence of elastosis than those with aged below 
49 (p < 0.05) (Table 6). 
The histological distribution of breast carcinoma 
according to the classification proposed by the 
Japanese Breast Cancer Society is shown in Table 
7. Elastosis was evaluated separately in the 
periductal region or in the stroma. Two-thirds of 
(a) 
Table 4. Relationship between Degree of Periductal 
Elastosis and Degree of Epitheliosis in Fibrocystic 
Disease 
Degree of Total no. 
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Fig. 3. Radial scar with periductal elastosis. (a: H&E stain, b: EVG stain, x 25) 
Table 5. Relationship between Degree of Elastosis and 
Degree of Epithelial Proliferation in Radial Scar 
Degree of No. of lesions (%) with 
epithelial Total no. elastosis at degrees of: 
proliferation of lesions + ++ +++ 
12 1 (8) 3 (25) 8 (67) 
+ 13 1 (8) 4 (31) 8 (62) 
++ 7 1 (14) 1 (14) 5 (71) 
Total 32 3 (9) 8 (25) 21 (66) 
(N.S.) 
Table 6. Relationship between Degree of All Types of 
Elastosis in Breast Carcinoma and Age of Patients 
No. of cases (%) with 
Total no. of elastosis at degrees of: 
Age cases + 
~49 62 19 (31) 43 (69) 
50~ 59 8 (14) 51 (86) 
Total 121 27 (22) 94 (78) 
(p<0.05) 
Table 7. Relationship between Histological type of Breast Carcinoma and Degree of Periductal and Stromal Elastosis 
No. of cases (%) with: 
Total no. Periductal elastosis at degrees of: Stromal elastosis at degrees of: 
Histological type of carcinoma of cases + ++ + ++ 
Noninvasive ductal carcinoma 19 7 (37) 10 (53) 2 (11) 
Invasive ductal carcinoma 
Papillotubular carcinoma 16 9 (56) 5 (31) 2 (13) 13 (81) 2 (13) 1 (6) 
Solid-tubular carcinoma 20 6 (40) 7 (47) 2 (13) 9 (45) 11 (55) 0 
Scirrhous carcinoma 57 3 (5) 14 (25) 40 (70) 8 (14) 18 (32) 31 (54) 
Medullary carcinoma 2 2 (100) 0 0 2 (100) 0 0 
Lobular carcinoma 3 2 (67) 1 (33) 0 2 (67) 1 (33) 0 
Tubular carcinoma 3 1 (33) 1 (33) 1 (33) 0 2 (67) 1 (33) 
Mucinous carcinoma 1 1 (100) 0 0 0 1 (100) 0 
Elastosis in Breast 91 
(a) (b) 
Fig. 4. Noninvasive carcinoma with periductal elastosis. (a: H&E stain, b: EVG stain, x 33) 
(a) (b) 
Fig. 5. Scirrhous carcinoma with stromal elastosis. (a: H&E stain, b: EVG stain, x 33) 
(a) (b) 
Fig. 6. Immunoreactivity of EL(a) and ACT(b) in normal ductal cells were noted. (ABC method, x 33) 
cases with non-invasive ductal carcinoma showed 
periductal elastosis (Fig. 4-a). Periductal elastosis 
is observed markedly in Fig. 4-b. It is evident that 
stromal elastosis is related to the invasive growth 
of the carcinoma and to the degree of diff erentia-
tion among the invasive carcinoma (Fig. 5-a). 
Marked stromal elastosis is observed in scirrhous 
carcinoma (Fig. 5-b). Periductal elastosis was also 
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Table 8. Relationship between Degree of Stromal Elastosis and Degree of Immunoreactivity of EL and ACT in 
Fibroadenoma 
No. of cases with: 
Degree of 
EL in epithelial cells at degrees of: ACT in epithelial cells at degrees of: stromal Total no. of 
elastosis cases + ++ + ++ 
37 20 (54) 13 (35) 4 (11) 1 (3) 14 (38) 22 (59) 
+ 16 9 (56) 5 (31) 2 (13) 0 8 (50) 8 (50) 
++ 3 3 (100) 0 0 0 2 (66) 1 (33) 
Total 56 32 (57) 18 (32) 6 (11) 1 (2) 24 (43) 31 (55) 
(N.S.) (N.S.) 
Table 9. Relationship between Degree of Epithelial Proliferation and Degree of Immunoreactivity of EL and ACT 
in Fibroadenoma 
No. of cases (%) with: 
Degree of 















Fig. 7. Immunoreactivity of EL in fibroadenoma was 


















Fig. 8. Immunoreactivity of ACT in fibrocystic dis-
ease was noted. (ABC method, x 50) 
Table 10. Relationship between Degree of Periductal Elastosis and Degree of Immunoreactivity of EL and ACT in 
Fibrocystic Disease 
Degree of 
No. of cases (%) with: 
periductal Total no. of EL in epithelial cells at degrees of: ACT in epithelial cells at degrees of: 
elastosis cases + ++ + ++ 
10 7 (70) 3 (30) 0 0 7 (70) 3 (30) 
+ 10 8 (80) 2 (20) 0 1 (10) 4 (40) 5 (50) 
++ 3 3 (100) 0 0 1 (33) 2 (66) 0 
Total 23 18 (78) 5 (22) 0 2 (9) 13 (57) 8 (35) 
(N.S.) (N.S.) 
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related to invasive growth, and thus scirrhous car-
cinoma showed the highest incidence. 
2. Immunohistochemistry of elastase (EL) and a 
1-antichymotrypsin (ACT) 
(1) Localization of EL and ACT in normal breast 
The constituent cells in the normal lobule were 
positive for EL and ACT. The relation to patients' 
age was not significant. It is uncertain whether one 
cell simultaneously had a positive finding of both 
EL and ACT. The myoepithelial cells were positive 
for both EL and ACT. The constituent cells in the 
normal duct were positive for EL and ACT (Fig. 
6). No correlation to the patients' age was noted, 
as with the lobule. 
(2) EL and ACT in fibroadenoma 
The proportion of fibroadenoma with positive EL 
and ACT in the epithelial cells was 43% and 98%, 
respectively. Table 8 shows the correlation between 
stromal elastosis and the positivity of EL and ACT 
in the epithelial cells. EL was not detected in the 
cases with marked elastosis, but there was no 
correlation between the degree of elastosis and the 
positivity of ACT in the epithelial cells. As shown 
in Table 9, the fibroadenoma with marked epithelial 
proliferation had a higher frequency of positive EL 
(p<0.05) (Fig. 7) and a greater positivity of ACT. 
The positivity of EL was not related to that of 
ACT in any of the epithelial cells. 
(3) EL and ACT in fibrocystic disease (epitheliosis) 
The proportion of fibrocystic disease (epitheliosis) 
with positive EL and ACT in epithelial cells was 
22% and 91 %, respectively (Table 10). As with 
fibroadenoma, the number of cases with positive 
ACT (Fig. 8) was larger than those with positive 
EL. 
EL was not detected in cases with marked elasto-
sis, as with fibroadenoma. There was no correla-
tion between the degree of elastosis and the 
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Table 12. Relationship between Degree of Periductal Elastosis and Degree of Immunoreactivity of EL and ACT in 
Radial Scar 
Degree of 
No. of lesions (%) with: 
periductal Total no. of EL in epithelial cells at degrees of: ACT in epithelial cells at degrees of: 
elastosis lesions + ++ + ++ 
+ 3 2 (67) 1 (33) 0 0 1 (33) 2 (67) 
++ 8 5 (63) 2 (25) 1 (13) 2 (25) 4 (50) 2 (25) 
+++ 21 11 (52) 8 (38) 2 (10) 7 (33) 8 (38) 6 (29) 
Total 32 18 (56) 11 (34) 3 (9) 9 (28) 13 (41) 10 (31) 
(N.S.) (N.S.) 
Table 13. Relationship between Degree of Epithelial Proliferation and Degree of Immunoreactivity of EL and ACT 
in Radial Scar 
Degree of 
No. of cases (%) with: 
epithelial Total no. of EL in epithelial cells at degrees of: ACT in epithelial cells at degrees of: 
proliferation cases + ++ +++ + ++ +++ 
12 6 (50) 5 (42) 1 (8) 6 (50) 3 (25) 3 (25) 
+ 13 8 (62) 3 (23) 2 (15) 2 (15) 7 (54) 4 (31) 
++ 7 4 (57) 3 (43) 0 1 (14) 3 (43) 3 (43) 
(N.S.) (N.S.) 
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Table 14. Relationship between Degree of Periductal Elastosis and Degree of Immunoreactivity of EL and ACT in 
Cancer Cells 
No. of cases (%) with: 
Degree of 
periductal Total no. of EL in cancer cells at degrees of: ACT in cancer cells at degrees of: 
elastosis cases + ++ + ++ 
30 17 (57) 7 (23) 6 (20) 14 (47) 4 (13) 12 (40) 
+ 38 4 (11) 17 (45) 17 (45) 9 (24) 5 (13) 24 (63) 
++ 48 16 (33) 13 (27) 19 (40) 10 (21) 9 (19) 29 (60) 
Total 116 37 (32) 37 (32) 42 (36) 33 (28) 18 (16) 65 (56) 
(N.S.) (N.S.) 
Table 15. Relationship between Degree of Stromal Elastosis and Degree of Immunoreactivity of EL and ACT in Cancer 
Cells 
No. of cases (%) with: 
Degree of 
stromal Total no. of EL in cancer cells at degrees of: ACT in cancer cells at degrees of: 
elastosis cases + ++ + ++ 
34 17 (50) 10 (29) 7 (21) 17 (50) 2 (6) 15 (44) 
+ 35 12 (34) 10 (29) 13 (37) 12 (34) 8 (23) 15 (43) 
++ 33 8 (24) 12 (36) 13 (39) 5 (15) 2 (6) 26 (79) 
Total 102 37 (36) 32 (31) 33 (32) 34 (33) 12 (12) 56 (55) 
(N.S.) (p<0.01) 
(a) (b) 
Fig. 9. Immunoreactivities of EL(a) and ACT(b) in noninvasive carcinoma. EL was markedly positive and 
ACT was moderately positive. (ABC method, x 33) 
positivity of ACT in the epithelial cells (Table 10). 
Table 11 shows the correlation between the degree 
of epitheliosis and the positivity of EL and ACT. 
There was no significant correlation between the 
two. The positivity of EL was not related to that 
of ACT in any of the epithelial cells. 
(4) EL and ACT in radial scar 
In radial scar, the proportion of cases with posi-
tive EL and ACT in the epithelial cells was 14% 
and 72%, respectively, and there was no correla-
tion between the degree of periductal elastosis and 
the positivity of EL and ACT in the epithelial cells 
(Table 12). Also, there was no correlation between 
the degree of epithelial proliferation and the posi-
tivity of EL and ACT in the epithelial cells (Table 
13). 
(5) EL and ACT in breast carcinoma 
The proportion of carcinoma with positivity of EL 
or ACT was 68% and 72%, respectively. EL was 
detected more frequently compared to cases with 
benign disease, but ACT was detected less fre-
quently in cases with carcinoma. As shown in Ta-
bles 14 and 15, the degree of periductal elastosis 
showed no correlation with the positivity of EL or 
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Table 16. Relationship between Histological Type of Breast Carcinoma and Degree of Immunoreactivity of EL and 
ACT in Cancer Cells 
No. of cases (%) with: 
Total no. EL in cancer cells at degrees of: ACT in cancer cells at degrees of: 
Histological type of carcinoma of cases + ++ + ++ 
Noninvasive ductal carcinoma 19 3 (16) 7 (37) 9 (47) 2 (11) 7 (37) 10 (53) 
Invasive ductal carcinoma 
Papillotubular carcinoma 16 4 (25) 9 (56) 3 (19) 5 (31) 1 (6) 10 (63) 
Solid-tubular carcinoma 20 11 (55) 6 (30) 3 (15) 9 (45) 3 (15) 8 (40) 
Scirrhous carcinoma 57 17 (30) 15 (26) 25 (44) 16 (28) 6 (11) 35 (61) 
Medullary carcinoma 2 2 (100) 0 0 2 (100) 0 0 
Lobular carcinoma 3 2 (67) 1 (33) 0 1 (33) 0 2 (67) 
Tubular carcinoma 3 1 (33) 1 (33) 1 (33) 0 2 (67) 1 (33) 
Mucinous carcinoma 1 0 0 1 (100) 1 (100) 0 0 
Table 17. Relationship between Degree of Periductal Elastosis and Degree of Immunoreactivity of EL and ACT in 
Cancer Cells of Noninvasive Carcinoma 
No. of cases (%) with: 
Degree of 
periductal Total no. of EL in cancer cells at degrees of: ACT in cancer cells at degrees of: 
elastosis cases + ++ + ++ 
7 2 (29) 2 (29) 3 (43) 1 (14) 2 (29) 4 (57) 
+ 10 0 4 (40) 6 (60) 1 (10) 4 (40) 5 (50) 
++ 2 1 (50) 1 (50) 0 0 1 (50) 1 (50) 
Total 19 3 (16) 7 (37) 9 (47) 2 (11) 7 (37) 10 (53) 
(N.S.) (N.S.) 
Table 18. Relationship between Degree of Stromal Elastosis and Degree of Immunoreactivity of EL and ACT in Cancer 
Cells of Scirrhous Carcinoma 
No. of cases (%) with: 
Degree of 
stromal Total no. of EL in cancer cells at degrees of: ACT in cancer cells at degrees of: 
elastosis cases + 
8 4 (50) 1 (13) 
+ 18 5 (28) 4 (22) 
++ 31 8 (26) 10 (32) 
Total 57 17 (30) 15 (26) 
ACT in the cancer cells, but the degree of stromal 
elastosis clearly correlated with the positivity of 
ACT in the cancer cells (p < 0.01). 
On the basis of the histological type of breast car-
cinoma, noninvasive ductal carcinoma (Fig. 9) 
showed a higher frequency of positive EL and ACT 
in cancer cells than invasive carcinoma. In invasive 
carcinoma, there was no significant correlation bet-
ween the histological type and the positivity of EL 
and ACT (Table 16). There was no correlation bet-
ween the positivity of EL and ACT in any of the 
breast carcinoma. 
In noninvasive carcinoma, there was no correla-
tion between the degree of periductal elastosis and 
the positivity of EL and ACT in the cancer cells 
(Table 17). In scirrhous carcinoma (Fig. 10), there 
++ + ++ 
3 (38) 5 (63) 0 3 (38) 
9 (50) 6 (33) 4 (22) 8 (44) 
13 (42) 5 (16) 2 (6) 24 (77) 
25 (44) 16 (28) 6 (11) 35 (61) 
(N.S.) (p<0.05) 
was no correlation between the degree of stromal 
elastosis and the positivity of EL in the cancer 
cells, but a significant correlation was noted bet-
ween the degree of stromal elastosis and the posi-
tivity of ACT in the cancer cells (p < 0.05), as 
shown in Table 18. There was no correlation bet-
ween the positivity of EL and ACT in any of the 
scirrhous carcinoma. 
DISCUSSION 
Elastosis around the ducts in the breast was 
described in scirrhous carcinoma by Billroth in 1860 
followed by many pathological studies on this 
change. Early reports suggested that periductal 
elastosis resulted from the stagnation of secretion 
in carcinomatous lesions and that it represented a 
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(a) (b) 
Fig. 10. Immunoreactivities of EL(a) and ACT(b) in scirrhous carcinoma. EL was mildly positive and ACT 
was markedly positive. (ABC method, x 33) 
precancerous lesion20). Recently, with regard to 
breast carcinoma, attempts have been made to elu-
cidate the correlation of elastosis with histopatho-
logical parameters, hormone receptor status, clinical 
course, response to endocrine therapy, prognosis 
and survival3·6). Shivas and Douglas35) first found a 
clear correlation between the grade of elastosis and 
prognosis in patients with breast carcinoma. Their 
conclusion was supported by several other 
studies26•42), in most of which focal periductal 
elastosis was measured and ascertained to 
correlate with estrogen receptor positive status. A 
totally contrary conclusion was reached in other 
studies, most of which measured stromal or total 
elastosis showing that marked elastosis correlated 
with estrogen receptor positive status, but no 
correlation shown between elastosis and 
prognosis1•16•31•34). More recently, Humeniuk et al17) 
reported that focal elastosis was a disappointing in-
dicator of prognosis, because the elastosis grade 
correlated with the presence of axillary 
metastasis16), although it was more likely to be as-
sociated with carcinomas with differentiated 
characteristics11). A recent study in Japan, report-
ed by Tamura & Enjoji38\ revealed that 105 cases 
with moderate to marked elastosis had a higher 
survival rate than 197 cases with no or only mild 
elastosis, and that this characteristic could serve as 
a prognostic indicator, but a correlation also exist-
ed between elastosis and the histologic grade of the 
carcinoma. This led to the. consideration that well 
differentiated carcinomas progress slowly, and 
therefore contain more elastic tissue. 
Consequently, the value of elastosis as a prognos-
tic indicator in patients with breast carcinoma has 
remained unclear. However, it appears that periduc-
tal elastosis is influenced by the differentiation of 
breast carcinoma including the positive status of es-
trogen receptor, and therefore the prognosis of 
patients with breast carcinoma associated with 
periductal elastosis is better. On the basis of the 
above information, elastosis may not be directly 
related to the malignant behavior of breast car-
cinoma. 
In the present study, the degree of elastosis in 
breast carcinoma cases was compared according to 
histological type. Periductal elastosis was frequently 
seen in noninvasive ductal carcinoma, but among 
invasive ductal carcinoma, poorly differentiated car-
cinoma (scirrhous carcinoma) showed a higher fre-
quency. This observation did not necessarily support 
the previous view. The fact that stromal elastosis 
was frequently seen in scirrhous carcinoma sug-
gests that the degree of elastosis should be evalu-
ated separately according to the anatomical sites. 
It is possible that the mechanism of elastosis is 
different between the periductal and stromal sites. 
In 1977, Martinez-Hernandes et al25) stated that 
benign conditions, such as fibroadenoma and 
sclerosing adenosis, did not produce significant 
elastosis. In the same year, however, Tremblay et 
al40) reported elastosis in 17 cases of benign 
sclerosing ductal proliferation of the female breast. 
Azzopardi3) stated that some lesions of epitheliosis, 
sclerosing adenosis and duct ectasia are accompa-
nied by elastosis. Recently, Parfrey et al3°) indicat-
ed that elastosis is a feature of fibrocystic disease 
and that the degrees of both stromal and periduc-
tal elastosis are related to the severity of epitheli-
osis. They confirmed that elastosis is not confined 
to carcinoma of the breast and that the degree of 
elastosis, especially stromal, increases progressive-
ly with the severity of breast disease, that is, from 
fibrocystic disease with increasingly severe epitheli-
osis, to noninvasive carcinoma, to invasive carcino-
ma. A peculiar hypothesis was proposed by them30) 
that the epithelial cells of fibrocystic disease, as 
well as breast carcinoma cells, induce fibroblast to 
overproduce elastic fibers. 
In the present study, elastosis associated with be-
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nign breast disease including not only fibrocystic 
disease but also radial scar and fibroadenoma was 
examined. Consequently, the result that periductal 
elastosis in fibrocystic disease shows an increasing 
tendency with the degree of epithelial proliferation 
confirms the findings of Parfrey et al30). So far, 
no report is available on elastosis in fibroadenoma. 
It is interesting to note that in fibroadenoma a 
similar tendency to fibrocystic disease is seen. A 
common biological nature is suggested in epitheli-
al proliferation of fibroadenoma and fibrocystic 
disease. 
As mentioned above, elastosis has been a focus 
of interest, chiefly in relation to the presence of 
breast disease including carcinoma and fibrocystic 
disease. However, it has not been clear what 
degree of elastosis is observed in normal or healthy 
breast10). The amount of elastic fibers varies con-
siderably according to the anatomical site, that is, 
periductal, stromal and perivascular3•6). There is a 
lack of agreement on the response of elastic tissue 
to fundamental physiological events, for example 
aging10). In some studies on breast with carcino-
ma, changes in elastic fibers with age, parity and 
reproductive status were an important concern, but 
the results in these breasts have been inconsistent. 
In general, it is accepted that elastosis is related 
to parity8•10•26•32•38). It makes sense to hypothesize 
that stimulus to the breast associated with lacta-
tion is reflected in an increase in bulk of elastic 
fibers, and that this could be recognized long after 
the event. However, this is not in agreement with 
some reports that no consistent diminution in elas-
tic fibers occurs by decade3•10•32). The relationship 
to aging is not clear8•25•32). 
In the present study, normal or healthy breasts 
were not selected as materials and the correlation 
between elastosis and aging was considered in the 
lesions of fibroadenoma, fibrocystic disease and 
breast carcinoma. The fact that stromal elastosis 
in fibroadenoma and periductal or stromal elasto-
sis in breast carcinoma increase in the older age 
group, suggests that aging in the breast can not 
be excluded as a factor in the morphogenesis of 
elastosis, even if the elastosis is within benign or 
malignant breast disease. However, it remains un-
certain whether aging only implies the influence of 
parity or whether other complicated factors as-
sociated with aging play a role in the morpho-
genesis of elastosis. 
It has been suggested that elastic fibers are resis-
tant to degradation and, once deposited, elastic tis-
sue will tend to remain because of this property. 
Therefore periductal elastic fibers show progressive 
deposition during the reproductive years and per-
sist for life10). Consequently, it was proposed that 
elastosis is a monument to past events and not an 
active process, and so, this term should be reserved 
for use in premenopausal women in whom high 
grades of elastosis are uncommon10). 
On the contrary, in the report of elastosis in 
breast diseases examined by immunohistochemistry 
for elastin and electron microscopy41), stromal 
elastosis was thought to be newly formed because 
it consisted of tannic acid-positive amorphous com-
ponents and abundant microfibrils; periductal 
elastosis supposedly consisted of numerous fine 
amorphous components with plentiful microfibrils or 
condensed accumulation of irregularly arranged 
small amorphous components associated with only 
a few microfibrils, and were thought to be formed 
by excess production of elastic fibers and degrada-
tion of pre-existing and newly formed-elastic fibers. 
Similar changes of elastic fibers have been report-
ed in experimental paraquat-treated lung12•13) and 
solar elastosis in skin7). Fukuda et al14) studied 
elastic fibers in patients with panacinar or centria-
cinar emphysema by electron microscopy and im-
munohistochemistry of elastin and found finely 
disrupted fibers presumed to have been damaged 
by elastase, small round amorphous components in 
elastic fibers, which might be formed from abnor-
mal elastogenesis, and large confluent elastic mass-
es, thought to be formed by aggregation in areas 
undergoing structural remodeling of the alveolar 
wall. Also, Fukuda et al15) reported that the 
emphysema-like lesions of lymphangiomyomatosis 
were mediated by the degradation of elastic fibers, 
and that degraded elastic fibers were related to an 
imbalance of the elastase I a 1-antitrypsin system. 
On the basis of these facts, it seems that the elas-
tic fibers present in the normal status of various 
organs including breast, are not resistant to 
degradation22). 
From the viewpoint of an imbalance of elastino-
genesis over elastinolysis, an evaluation of levels of 
elastinolytic enzymes in the lesion of elastosis is 
necessary. However, it is possible that much 
elastinolytic enzyme activity is attenuated by pro-
tease inhibitors such as a 1-antitrypsin, a 
1-antichymotrypsin or a 2-macroglobulin, and that 
an excess of protease inhibitors relative to proteo-
lytic enzymes may lead to overproduction of elas-
tic fibers in the breast. Davies and Mera9) 
reported that the immunoreactivities of protease in-
hibitors including a 1-antichymotrypsin were found 
in the fibers of elastosis. They suggested that ex-
tracellular regulation of enzymatic degradation oc-
curs and that the plasma- or tissue-derived protease 
inhibitors are involved in the modulation of enzyme 
activity during morphogenesis of elastosis, also that 
the increased concentration of protease inhibitors, 
relative to elastinolytic enzymes, contributes to 
overproduction of elastic fibers in elastosis of the 
breast. 
So far, elastatinal, Meo-Suc-(Ala)2-Pro-Val-
CH2CL, SR26831, a 1-antitrypsin and a 
1-antichymotrypsin and a 2-macroglobulin are 
known as elastase inhibitors and it is uncertain 
which is most effective as an elastase inhibitor. 
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Among them, the ones available to the paraffin-
embedded material are ct 1-antitrypsin, ct 
1-antichymotrypsin and ct 2-macroglobulin. There-
fore, the immunohistochemical staining using these 
three antibodies was performed in the present 
study and the results of ct 1-antichymotrypsin were 
only evaluated, because the positive finding of ct 
1-antitrypsin and ct 2-macroglobulin was limited. 
In the report by Davies and Mera9\ the cellular 
origin of elastase and protease inhibitors was not 
described. The present study was attempted, there-
fore, to ascertain the source of elastase (EL) and 
a representative of protease inhibitor, ct 1-anti-
chymotrypsin (ACT). Immunohistochemical observa-
tion of epithelium in the normal lobule and duct of 
breast revealed immunoreactivities of EL and ACT. 
This fact suggests that production of EL and ACT 
is a normal function of breast epithelium. Further-
more, the observation that fibrocystic disease ac-
companies elastosis as well as breast carcinoma and 
that inflammatory cells including neutrophils or 
histiocytes are not prominent in most fibrocystic 
disease and breast carcinoma, indicates that duc-
tal epithelial proliferation with preserved produc-
tion of enzymes, either in the benign or malignant 
disease, plays a significant role in the occurrence 
of elastosis. 
The present study has shown a different role for 
EL and ACT in benign and malignant breast dis-
ease. In fibroadenoma and fibrocystic disease, it is 
probable that marked epithelial proliferation lacks 
production of EL, and the ACT produced in 
epithelial cells ceases elastinolysis. On the other 
hand, the role of EL and ACT is variable among 
the histological types of carcinoma. In noninvasive 
ductal carcinoma, carcinoma cells preserve the 
productive activity of EL and ACT, but the degree 
of periductal elastosis is not related to the positiv-
ity of EL and ACT. Therefore, it seems that an 
imbalance of these enzymes is not related to the 
periductal elastosis. In invasive ductal carcinoma, 
however, the productive activity of ACT in carci-
noma cells is related to stromal elastosis. In par-
ticular, scirrhous carcinoma shows a significant 
correlation between ACT in cancer cells and 
stromal elastosis. 
The localization of EL in breast disease has not 
been reported so far, and the present study re-
vealed a wide distribution of this enzyme and its 
significant role in the morphogenesis of elastosis. 
The immunohistochemical distribution of type IV 
collagenase in normal, benign and malignant breast 
has been recently reported29>, in which collagenase 
was frequently detected in the epithelial cells of the 
normal terminal ducts and hyperplastic lesion. Also, 
intraductal carcinoma and invasive carcinoma as 
well as metastasis in lymph nodes has shown posi-
tive immunoreactivity of this enzyme29>. The result 
supported the role of type IV collagenase in the 
basement membrane remodeling of normal breast 
and in the invasion and metastasis of breast carci-
noma. It has now become· .clear that the epithelial 
cells of the breast have the capacity to produce pro-
teolytic enzyme including elastase and collagenase. 
Each of these enzymes appears to have a differ-
ent role in the normal breast and in the pathologi-
cal process and plays a role in the peculiar 
morphogenesis. 
ct 1-antichymotrypsin is an acute-phase plasma 
protease inhibitor and was first described in 1965. 
The physiological role of this enzyme has not yet 
been fully elucidated. Although a number of func-
tions are recognized, it is certain that this enzyme 
is involved in the defense mechanism against pro-
tease and inhibits antibody-dependent cell-mediated 
cytotoxicity in vitro. So far the immunoreactivity 
of this enzyme has been reported in a large num-
ber of different types of tumors24>, and it was sug-
gested that its presence is of little value in the 
differential diagnosis of either sarcomas or carci-
nomas. The immunoreactivity of ACT, in relation 
to various kinds of breast disease, has not been 
available in previous reports, but the present study 
has revealed that ACT plays a different role in the 
morphogenesis of elastosis among different types 
of breast disease. 
On the other hand, the cellular origin of elastic 
fiber in the breast, either benign or with healthy-
normal or malignant disease, remains uncertain. 
Two hypotheses have been suggested to explain the 
cellular origin of elastosis associated with breast 
carcinoma. Firstly, the carcinoma cells themselves 
may be responsible for the secretion of the materi-
al. In support of this hypothesis, it is reported that 
cultured breast carcinoma cells secrete collagen and 
elastin, although the amounts are small compared 
with cultured fibroblasts21>. Recently, it was 
reported that the human breast cancer cell lines 
produce elastin in culture at rates equivalent to 
1.6-15% of those of control fibroblastic cells, and 
northern blot analysis of total RNA showed the 
presence of a 3.5 kilobase elastin mRNA band in 
both the fibroblastic cells and the cancer cells 
lines23>. Also, by use of in situ hybridization with 
an elastin complementary RNA probe, malignant 
cells of some breast carcinoma have been shown to 
be responsible for elastin synthesis23>. Alternative-
ly, it has been suggested that an inductive factor 
is secreted by carcinoma cells4•39> and such a fac-
tor influences periductal fibroblasts, vascular 
smooth muscle cells or fibroblasts, causing myo-
fibroblastic differentiation and the biosynthesis of 
elastic fibers. 
Ultrastructural observation has revealed that 
myofibroblasts are not a component of normal 
breast stroma, but are a prominent feature in the 
stroma of invasive ductal carcinoma36•37>. These 
findings suggest that myofibroblastic proliferation 
around invasive carcinoma occurs. Myofibroblasts 
are known to have well-developed synthetic and 
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contractile properties and the presence of myo-
fibroblasts within the lesion with elastosis suggests 
that these cells are responsible for the morphogen-
esis of elastosis. Another report described the 
presence of myofibroblasts in radial scars and sug-
gested that focal loss of basal lamina could contrib-
ute to the myofibroblastic reaction and consequently 
to the elastosis seen in the radial scar5). 
The study by use of in situ hybridization with an 
elastin complimentary RNA probe revealed that 
fibroblastic cells in the stroma and in the periduc-
tal region were responsible for elastin synthesis in 
most breast carcinoma23). Vascular endothelium 
also expressed the elastin gene in some breast car-
cinomas. From these results, it was speculated that 
the elastotic elastin might have different cellular 
origins in different portions of a single ductal car-
cinoma, and elastosis in breast carcinomas was 
likely to be a complex process with multifactorial 
regulatory mechanisms23). Other reports are in 
agreement with this view32•38). 
Recently the attention of many investigators has 
focused on the potential roles of soluble or secret-
ed factors, the so-called growth factors, in modulat-
ing cell-cell communication in the normal and 
abnormal regulation of tissue growth and 
maturation2). Cultured human breast cancer cells 
have been shown to produce and respond to a num-
ber of growth factors, such as insulin-like growth 
factor II (IGF-II), epidermal growth factor (EGF), 
transforming growth factor-a (TGF-a) and TGF-,B. 
Most benign and malignant breast lesions involve 
abnormal proliferation and altered architecture of 
the stromal and/or epithelial elements. It is thus 
reasonable to hypothesize that altered cellular ex-
pression or response to growth factors in the breast 
play a role in the development, persistence or 
regression of such lesions27). With regard to mor-
phogenesis of the elastosis in the breast, it might 
be important to consider some growth factors and 
inductive factors to elastin production. From this 
point of view, further investigations are necessary. 
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